Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Is Epigenetic Modulation to Induce Fetal Hemoglobin Translatable in Sickle Cell Mice?

Ariadna Carol Illa, Jesper Petersen, Søren Skov, Andreas Glenthoej, Carsten Dan Ley

Blood (2023) 142 (Supplement 1): 5261.

https://doi.org/10.1182/blood-2023-173922

Published: 2023

Journal Articles

Clinical Outcome of Covid-19 in Haematologic Malignancy Patients with a Fourth Dose of Anti-Sars-Cov-2 Vaccine: A Final Epicovideha Report

Meinolf Karthaus, Jon Salmanton-García, Francesco Marchesi, Andreas Glenthoej, Yavuz M Bilgin, Jens Van Praet, Laman Rahimli, Oliver Cornely, Livio Pagano

Blood (2023) 142 (Supplement 1): 7262.

https://doi.org/10.1182/blood-2023-189041

Published: 2023

Journal Articles

Decoding the Historical TALE: COVID-19 Impact on Hematological Malignancy Patients - Insights from 2020 to 2022

Francesco Marchesi, Jon Salmanton-García, Francesca Farina, Barbora Weinbergerova, Federico Itri, Julio Dávila-Valls, Sonia Martín-Pérez, Andreas Glenthoej, Ditte Hersby, Maria Gomes Da Silva, Raquel Nunes-Rodrigues, Raul Cordoba, Alberto Lopez Garcia, Ziad Emarah, Shaimaa El-Ashwah, Yavuz M. Bilgin, Laman Rahimli, Oliver Cornely, Livio Pagano

Blood (2023) 142 (Supplement 1): 1067.

https://doi.org/10.1182/blood-2023-188942

Published: 2023

Journal Articles

Absolute and Relative Risks of Hematologic Disease and Cause-Specific Death in Individuals with Incidentally Discovered Thrombocytopenia: A Prospective Study of Two Independent General Population Cohorts Including 486,782 Individuals from the United Kingdom and Denmark

Anne Rudbeck Juhl, Andreas Glenthoej, Boerge Groenne Nordestgaard, Jesper Petersen, Morten Dahl, Christina Ellervik, Stig Egil Bojesen, Jens Helby

Blood (2023) 142 (Supplement 1): 395.

https://doi.org/10.1182/blood-2023-173792

Published: 2023

Journal Articles

Regional Genetic Heterogeneity Among Patients with Pyruvate Kinase Deficiency

Paola Bianchi, Elisa Fermo, Kevin H.M. Kuo, Dagmar Pospíšilová, Andreas Glenthoej, Carl Lander, Eduard J. Van Beers, Bertil Glader, Joan-Lluis Vives Corrons, Stefan W Eber, Yan Yan, Bryan McGee, Janet H Ford, Saliha Yilmaz, Rachael F. Grace

Blood (2023) 142 (Supplement 1): 5203.

https://doi.org/10.1182/blood-2023-181834

Published: 2023

Journal Articles

Safety and Efficacy of Mitapivat in Adult Patients with Erythrocyte Membranopathies (SATISFY)

Andreas Glenthoej, Eduard J. Van Beers, Richard van Wijk, Minke A.E. Rab, Evelyn Groot, Niels G Vejlstrup, Selma K Bendtsen, Nina Toft, Jesper Petersen, Jens Helby, Fatiha Chermat, Pierre Fenaux, Kevin H.M. Kuo

Blood (2023) 142 (Supplement 1): 1085.

https://doi.org/10.1182/blood-2023-173147

Published: 2023

Journal Articles

Mitapivat Improves Ineffective Erythropoiesis and Reduces Iron Overload in Patients with Pyruvate Kinase Deficiency

Eduard J. Van Beers, Hanny Al-Samkari, Rachael F. Grace, Wilma Barcellini, Andreas Glenthoej, Malia P. Judge, Penelope A. Kosinski, Emily Xu, Vanessa Beynon, Bryan McGee, John B. Porter, Kevin H.M. Kuo

Blood (2021) 138 (Supplement 1): 2005.

https://doi.org/10.1182/blood-2021-147317

Published: 2021

Journal Articles

Bone Mineral Density Remains Stable in Pyruvate Kinase Deficiency Patients Receiving Long-Term Treatment with Mitapivat

Hanny Al-Samkari, Rachael F. Grace, Andreas Glenthoej, Oliver Andres, Wilma Barcellini, Frédéric Galactéros, Kevin H.M. Kuo, D. Mark Layton, Marta Morado, Vip Viprakasit, Yan Dong, Feng Tai, Liz Grekas, Karishma Khoja, Sarah Gheuens, Bryan McGee, John B. Porter, Eduard J. Van Beers

Blood (2021) 138 (Supplement 1): 924.

https://doi.org/10.1182/blood-2021-147156

Published: 2021

Journal Articles

Durability of Hemoglobin Response and Reduction in Transfusion Burden Is Maintained over Time in Patients with Pyruvate Kinase Deficiency Treated with Mitapivat in a Long-Term Extension Study

Blood (2021) 138 (Supplement 1): 848.

https://doi.org/10.1182/blood-2021-147711

Published: 2021

Journal Articles

COVID-19 Infection in Vaccinated Adult Patients with Hematological Malignancies. Preliminary Results from Epicovideha (Epidemiology of COVID-19 infection in patients with hematological malignancies: A European Haematology Association Survey)

Francesco Marchesi, Jon Salmanton-García, Alberto Lopez-Garcia, Giulia Dragonetti, Uluhan Sili, Andreas Glenthoej, Caterina Buquicchio, Malgorzata Mikulska, Barbora Weinbergerova, Alessandro Busca, Paolo Corradini, Martin Hoenigl, Nikolay N. Klimko, Antonio Pagliuca, Francesco Passamonti, Philipp Köhler, Oliver Cornely, Livio Pagano

Blood (2021) 138 (Supplement 1): 3733.

https://doi.org/10.1182/blood-2021-147295

Published: 2021

Journal Articles

Early-Onset Osteopenia and Osteoporosis in Patients with Pyruvate Kinase Deficiency

Hanny Al-Samkari, MD, Rachael F. Grace, MD, Andreas Glenthoej, MD, Oliver Andres, MD, Wilma Barcellini, Frédéric Galactéros, MDPhD, Kevin H.M. Kuo, MDMSc,FRCPC, D. Mark Layton, MB BS, Marta Morado, PhD, Vip Viprakasit, Yan Dong, PhD, Feng Tai, PhD, Peter Hawkins, PhD, Sarah Gheuens, MD PhD, Chris Bowden, MD, John B. Porter, MA, MD, FRCP, FRCPath, Eduard van Beers, MD PhD

Blood (2020) 136 (Supplement 1): 30–32.

https://doi.org/10.1182/blood-2020-136598

Published: 2020

Journal Articles

Red Blood Cell Deformability Demonstrated with the Oxygenscan: Exploring the Association with Hydroxyurea Treatment, Co-Inherited α-Thalassemia, and Frequency of Pain in Children with Sickle Cell Anemia

Amina Nardo-Marino, Jesper Petersen, Andreas Glenthoej, MD PhD, John N. Brewin, Joergen Kurtzhals, Thomas N. Williams, David C. Rees, Henrik Birgens

Blood (2019) 134 (Supplement_1): 4834.

https://doi.org/10.1182/blood-2019-129836

Published: 2019

NARROW

Is Epigenetic Modulation to Induce Fetal Hemoglobin Translatable in Sickle Cell Mice?

Clinical Outcome of Covid-19 in Haematologic Malignancy Patients with a Fourth Dose of Anti-Sars-Cov-2 Vaccine: A Final Epicovideha Report

Decoding the Historical TALE: COVID-19 Impact on Hematological Malignancy Patients - Insights from 2020 to 2022

Absolute and Relative Risks of Hematologic Disease and Cause-Specific Death in Individuals with Incidentally Discovered Thrombocytopenia: A Prospective Study of Two Independent General Population Cohorts Including 486,782 Individuals from the United Kingdom and Denmark

Regional Genetic Heterogeneity Among Patients with Pyruvate Kinase Deficiency

Safety and Efficacy of Mitapivat in Adult Patients with Erythrocyte Membranopathies (SATISFY)

Mitapivat Improves Ineffective Erythropoiesis and Reduces Iron Overload in Patients with Pyruvate Kinase Deficiency

Bone Mineral Density Remains Stable in Pyruvate Kinase Deficiency Patients Receiving Long-Term Treatment with Mitapivat

Durability of Hemoglobin Response and Reduction in Transfusion Burden Is Maintained over Time in Patients with Pyruvate Kinase Deficiency Treated with Mitapivat in a Long-Term Extension Study

COVID-19 Infection in Vaccinated Adult Patients with Hematological Malignancies. Preliminary Results from Epicovideha (Epidemiology of COVID-19 infection in patients with hematological malignancies: A European Haematology Association Survey)

Early-Onset Osteopenia and Osteoporosis in Patients with Pyruvate Kinase Deficiency

Red Blood Cell Deformability Demonstrated with the Oxygenscan: Exploring the Association with Hydroxyurea Treatment, Co-Inherited α-Thalassemia, and Frequency of Pain in Children with Sickle Cell Anemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only